CN110960648A - A Chinese medicinal composition for treating acute viral hepatitis - Google Patents

A Chinese medicinal composition for treating acute viral hepatitis Download PDF

Info

Publication number
CN110960648A
CN110960648A CN201811153375.6A CN201811153375A CN110960648A CN 110960648 A CN110960648 A CN 110960648A CN 201811153375 A CN201811153375 A CN 201811153375A CN 110960648 A CN110960648 A CN 110960648A
Authority
CN
China
Prior art keywords
parts
viral hepatitis
traditional chinese
acute viral
rhizome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811153375.6A
Other languages
Chinese (zh)
Inventor
成绵广
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201811153375.6A priority Critical patent/CN110960648A/en
Publication of CN110960648A publication Critical patent/CN110960648A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)
    • A61K36/12—Filicopsida or Pteridopsida
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/537—Salvia (sage)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/708—Rheum (rhubarb)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A61K36/744—Gardenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The embodiment of the invention discloses a traditional Chinese medicine composition for treating acute viral hepatitis, which belongs to the field of traditional Chinese medicines and is prepared from the following raw medicines: herba lycopi, radix curcumae, salvia miltiorrhiza, peach kernel, giant knotweed rhizome, lalang grass rhizome, gardenia, cyrtomium rhizome and raw rhubarb. The invention aims at the pathogenesis of acute viral hepatitis according to the theory of traditional Chinese medicine, performs dialectical formula treatment to achieve the purpose of treating both symptoms and root causes, and has the advantages of good curative effect, no toxic or side effect, easily obtained raw materials, low price, simple preparation, low production cost, convenient medicine use and the like.

Description

A Chinese medicinal composition for treating acute viral hepatitis
Technical Field
The invention relates to the field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for treating acute viral hepatitis.
Background
Viral hepatitis is an infectious disease mainly caused by liver diseases caused by various hepatitis viruses. Clinically, the symptoms of anorexia, nausea, epigastric discomfort, liver pain and hypodynamia are mainly manifested. Some patients may have jaundice fever and hepatomegaly with liver function impairment. Some patients can become chronic, even develop cirrhosis of the liver, and a few can develop liver cancer. Viral hepatitis is diagnosed, isolated, reported, treated and managed as early as possible to prevent its prevalence.
The disease is localized in the liver, gallbladder and spleen. The stomach and kidney are related to the zang-fu organs. The external cause is the pathogenic factors of epidemic toxin dampness-heat, the internal cause is the deficiency of healthy qi, and acute hepatitis is mainly caused by excess syndrome, mainly caused by dampness-heat pathogenic toxin, stagnation in spleen and stomach, fumigation of liver and gallbladder and obstruction of qi movement. Chronic hepatitis is caused by deficiency and excess, which are mainly caused by retention of exogenous pathogenic factors, disharmony of liver and spleen, deficiency of liver and kidney and obstruction of vessels. The pattern of gallbladder stasis is also complicated by deficiency and excess, and is mainly caused by retention of damp-heat, fumigating liver and gallbladder, spleen deficiency and blood stasis. Severe hepatitis is caused by exuberant epidemic toxin, transformation of fire into dryness, invasion of nutrient-blood, internal retention of pathogenic heat and loss of original qi.
Viral hepatitis is a group of infectious diseases mainly caused by liver diseases by various different hepatitis viruses, and according to etiological diagnosis, at least 5 kinds of hepatitis viruses, namely hepatitis A, hepatitis B, hepatitis C, hepatitis D and hepatitis E viruses, respectively cause the viral hepatitis A, hepatitis B, hepatitis C, hepatitis D and hepatitis E; another is called viral hepatitis type g, and less commonly, viral hepatitis is transmitted mainly through feces-mouth, blood or body fluid; clinically, fatigue, anorexia, hepatomegaly and abnormal liver function are taken as main manifestations, jaundice appears in some cases, asymptomatic infection is common, at present, some therapeutic traditional Chinese medicines are used for treating liver diseases, however, the traditional Chinese medicines in the prior art can not meet the requirements of patients with viral hepatitis in the aspects of treatment specificity and medicine diversity, and in the method for treating viral hepatitis, most of the traditional Chinese medicines do not well distinguish different clinical manifestations of different types, the used medicines are different, and the symptomatic treatment benefits of the traditional Chinese medicine in syndrome differentiation treatment are not well applied.
Disclosure of Invention
The invention provides a traditional Chinese medicine composition for treating acute viral hepatitis, which is prepared according to the theory of traditional Chinese medicine and by dialectical formula treatment, so as to achieve the purpose of treating both symptoms and root causes, and has the advantages of high curative effect, no toxic or side effect, easily available raw materials, low price, simple preparation, low production cost, convenient and various medicine application methods and the like.
In order to achieve the purpose, the invention adopts the following technical scheme through a large amount of grope and summary:
a traditional Chinese medicine composition for treating acute viral hepatitis is characterized by being prepared from the following raw medicines in parts by weight: 5-11 parts of herba lycopi, 5-11 parts of radix curcumae, 5-11 parts of salvia miltiorrhiza, 5-11 parts of peach kernel, 15-25 parts of giant knotweed, 15-25 parts of rhizoma imperatae, 9-15 parts of gardenia, 9-15 parts of cyrtomium rhizome and 7-11 parts of raw rhubarb.
Preferably, the traditional Chinese medicine composition for treating acute viral hepatitis is prepared from the following raw medicines in parts by weight: 7-9 parts of herba lycopi, 7-9 parts of radix curcumae, 7-9 parts of salvia miltiorrhiza, 7-9 parts of peach kernel, 18-22 parts of polygonum cuspidatum, 18-22 parts of rhizoma imperatae, 11-13 parts of gardenia, 11-13 parts of cyrtomium rhizome and 8-10 parts of raw rhubarb.
Preferably, the traditional Chinese medicine composition for treating acute viral hepatitis is prepared from the following raw medicines in parts by weight: 8 parts of herba lycopi, 8 parts of radix curcumae, 8 parts of salvia miltiorrhiza, 8 parts of peach kernel, 20 parts of polygonum cuspidatum, 20 parts of cogongrass rhizome, 12 parts of gardenia jasminoides, 12 parts of cyrtomium rhizome and 9 parts of raw rhubarb.
Further, the raw materials are weighed according to the weight, sterilized, dried, ground and sieved to prepare powder.
Further, the raw materials are weighed according to the weight, 250 parts of water is added, the raw materials are boiled with big fire and the raw materials are boiled with small fire for 30 minutes, and the liquid medicine is obtained after filtering residues.
Further, the prepared powder and/or liquid medicine can be further prepared into soft extract, tablets, capsules, syrups, granules, dripping pills, oral liquid or injection and the like by industrial preparation methods such as concentration, mixing, pressing and the like.
In the compatibility of the selected raw material traditional Chinese medicinal materials, the herba lycopi can activate blood and regulate menstruation, remove stasis and cure carbuncle, induce diuresis and reduce edema; radix Curcumae has effects in promoting blood circulation, relieving pain, activating qi-flowing, resolving stagnation, clearing heart fire, cooling blood, promoting bile flow, and eliminating jaundice; the salvia miltiorrhiza can activate blood and remove stasis, dredge meridians and relieve pain, clear heart and relieve restlessness, cool blood and cure carbuncle; peach kernel has the effects of promoting blood circulation, removing blood stasis, moistening intestines, relaxing bowels, relieving cough and asthma; rhizoma Polygoni Cuspidati has effects of promoting diuresis, eliminating jaundice, clearing away heat and toxic materials, dispelling blood stasis, relieving pain, relieving cough, and eliminating phlegm; the cogongrass rhizome can cool blood and stop bleeding, clear heat and induce diuresis; fructus Gardeniae has effects in purging pathogenic fire, relieving restlessness, clearing away heat, promoting diuresis, cooling blood, and removing toxic substances; externally used for detumescence and acesodyne; rhizoma Osmundae can clear heat; detoxification; cooling blood to stop bleeding; radix et rhizoma Rhei has effects in clearing away damp-heat, purging pathogenic fire, cooling blood, removing blood stasis, and removing toxic substance.
Detailed Description
Example 1
The traditional Chinese medicine composition is prepared by weighing the following components: 8 parts of herba lycopi, 8 parts of radix curcumae, 8 parts of salvia miltiorrhiza, 8 parts of peach kernel, 20 parts of polygonum cuspidatum, 20 parts of cogongrass rhizome, 12 parts of gardenia jasminoides, 12 parts of cyrtomium rhizome and 9 parts of raw rhubarb, boiling for 30 minutes with soft fire, and filtering residues to obtain liquid medicine.
Example 2
The traditional Chinese medicine composition is prepared by weighing the following components: 8 parts of herba lycopi, 9 parts of radix curcumae, 9 parts of radix salviae miltiorrhizae, 8 parts of peach kernel, 20 parts of polygonum cuspidatum, 21 parts of lalang grass rhizome, 12 parts of gardenia, 12 parts of cyrtomium rhizome and 10 parts of raw rhubarb, fully dried, stirred and ground into powder, and the powder is taken with water in the morning and evening.
Example 3
The traditional Chinese medicine composition is prepared by weighing the following components: 9 parts of herba lycopi, 8 parts of radix curcumae, 8 parts of radix salviae miltiorrhizae, 8 parts of peach kernel, 20 parts of giant knotweed rhizome, 20 parts of lalang grass rhizome, 11 parts of gardenia, 11 parts of cyrtomium rhizome and 9 parts of raw rhubarb, fully drying, stirring, grinding into powder, and encapsulating to be taken in the morning and evening.
The above disclosure is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the scope of the present invention, therefore, the present invention is not limited by the appended claims.

Claims (4)

1. A traditional Chinese medicine composition for treating acute viral hepatitis is characterized by being prepared from the following raw medicines in parts by weight: 5-11 parts of herba lycopi, 5-11 parts of radix curcumae, 5-11 parts of salvia miltiorrhiza, 5-11 parts of peach kernel, 15-25 parts of giant knotweed, 15-25 parts of rhizoma imperatae, 9-15 parts of gardenia, 9-15 parts of cyrtomium rhizome and 7-11 parts of raw rhubarb.
2. The traditional Chinese medicine composition for treating acute viral hepatitis according to claim 1 is characterized by being prepared from the following raw medicines in parts by weight: 7-9 parts of herba lycopi, 7-9 parts of radix curcumae, 7-9 parts of salvia miltiorrhiza, 7-9 parts of peach kernel, 18-22 parts of polygonum cuspidatum, 18-22 parts of rhizoma imperatae, 11-13 parts of gardenia, 11-13 parts of cyrtomium rhizome and 8-10 parts of raw rhubarb.
3. The traditional Chinese medicine composition for treating acute viral hepatitis according to claim 2 is characterized by being prepared from the following raw medicines in parts by weight: 8 parts of herba lycopi, 8 parts of radix curcumae, 8 parts of salvia miltiorrhiza, 8 parts of peach kernel, 20 parts of polygonum cuspidatum, 20 parts of cogongrass rhizome, 12 parts of gardenia jasminoides, 12 parts of cyrtomium rhizome and 9 parts of raw rhubarb.
4. The Chinese medicinal composition for treating acute viral hepatitis according to any one of claims 1 to 3, which is in the form of soft extract, tablet, capsule, syrup, granule, drop pill, oral liquid or injection.
CN201811153375.6A 2018-09-29 2018-09-29 A Chinese medicinal composition for treating acute viral hepatitis Pending CN110960648A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811153375.6A CN110960648A (en) 2018-09-29 2018-09-29 A Chinese medicinal composition for treating acute viral hepatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811153375.6A CN110960648A (en) 2018-09-29 2018-09-29 A Chinese medicinal composition for treating acute viral hepatitis

Publications (1)

Publication Number Publication Date
CN110960648A true CN110960648A (en) 2020-04-07

Family

ID=70028283

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811153375.6A Pending CN110960648A (en) 2018-09-29 2018-09-29 A Chinese medicinal composition for treating acute viral hepatitis

Country Status (1)

Country Link
CN (1) CN110960648A (en)

Similar Documents

Publication Publication Date Title
WO2022036779A1 (en) Huashibaidu granule, preparation method therefor and anti-viral drug
CN103055222A (en) Medicine for treating tinea manus and pedis
CN102462827A (en) Traditional Chinese medicinal powder formulation for treating postpartum mastitis of Boer goat
CN101129872A (en) Powder of phellodendron amurense adlay erysipelas
CN1177599C (en) Chinese medicine for treating burn and scald and its preparing process
CN105456390A (en) Clinical mixed preparation for cardiovascular department and preparation method
CN110960648A (en) A Chinese medicinal composition for treating acute viral hepatitis
CN100579544C (en) Chinese medicament preparation for treating cholecystitis and gall-stone as well as preparation method thereof
CN101224281B (en) Chinese traditional medicine preparation for purulent inflammation of skin
CN102895507B (en) Chinese medicine for treating leukoplakia vulvae and preparation method thereof
CN1053832C (en) Chinese patent drug for cirrhosis of liver
CN100382833C (en) Mastosis treating Chinese medicine
CN103656323A (en) Traditional Chinese medicine for treating erythroderma-type psoriasis
CN1132603C (en) Compound Wuduqing capsule of blister beetle
CN103041202A (en) Chinese herbal medicine for treating nasosinusitis
CN103432337B (en) Traditional Chinese medicine decoction
CN101991696A (en) Chinese material medical preparation for treating urticaria
CN110882331A (en) Traditional Chinese medicine composition for treating acute icteric viral hepatitis
CN102018800A (en) Traditional Chinese medicinal preparation for treating heat type constipations
CN106177250A (en) A kind of Chinese medicine composition treating chronic nephritis
CN1559471A (en) Chinese medicine/preparation
CN105477246A (en) Traditional Chinese medicine composition for treating phlegmatic hygrosis type mammary gland hyperplasia and preparation method thereof
CN102274432A (en) Chinese medicinal preparation for treating vaginal discharge diseases
CN117018131A (en) Traditional Chinese medicine composition for treating persistent HPV infection and preparation method thereof
CN103100050B (en) Chinese medicament for treating angina

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20200407

WD01 Invention patent application deemed withdrawn after publication